{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:13:23Z","timestamp":1768526003182,"version":"3.49.0"},"posted":{"date-parts":[[2025,9,3]]},"group-title":"Cell Biology","reference-count":46,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institutes of Health National Heart Lung and Blood Institute","award":["R00HL177830"],"award-info":[{"award-number":["R00HL177830"]}]},{"name":"American Society of Hematology Scholar Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Sepsis is a life-threatening condition characterized by dysregulated host responses to infection. Here, we identify platelet factor 4 (PF4) as a key mediator of vascular antimicrobial defense. In vitro, PF4 enhanced endothelial cell internalization of\n                  <jats:italic>Escherichia coli<\/jats:italic>\n                  via interactions with the PF4 receptor CXCR3 and the endothelial glycocalyx, directing bacteria to clathrin-mediated endocytosis and lysosomal degradation. In vivo, PF4 administration improved survival and reduced sepsis severity, bacterial burden, inflammation, and thrombosis in wild-type (WT) and PF4 knockout (\n                  <jats:italic>PF4<\/jats:italic>\n                  <jats:sup>\n                    \u2212\n                    <jats:italic>\/<\/jats:italic>\n                    \u2212\n                  <\/jats:sup>\n                  ) mice challenged with systemic polymicrobial infection. Using intravital microscopy, we observed that infused bacteria were rapidly sequestered in the pulmonary microvasculature. However,\n                  <jats:italic>PF4<\/jats:italic>\n                  <jats:sup>\n                    \u2212\n                    <jats:italic>\/<\/jats:italic>\n                    \u2212\n                  <\/jats:sup>\n                  mice exhibited impaired bacterial clearance and increased microvascular platelet adhesion and aggregation. In the liver, following Kupffer cell depletion,\n                  <jats:italic>PF4<\/jats:italic>\n                  <jats:sup>\n                    \u2212\n                    <jats:italic>\/<\/jats:italic>\n                    \u2212\n                  <\/jats:sup>\n                  mice had increased sinusoidal platelet accumulation, larger bacterial aggregates, and elevated hepatic bacterial burden compared to WT controls. Collectively, these findings reveal that PF4 promotes bacterial clearance and restrains immunothrombosis during sepsis in part via endothelial cell uptake and destruction of microbes. By enhancing endothelial antimicrobial function, PF4 represents a significant yet previously underrecognized host defense mechanism that limits bacterial spread and alleviates vascular injury during infection.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>KEY POINTS<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>In vitro, PF4 accelerates bacterial clearance by enhancing endothelial uptake of bacteria and promoting their trafficking to the lysosome.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>In murine sepsis, PF4 augments pathogen clearance to reduce infection severity, limit organ injury, and improve survival.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.1101\/2025.09.02.673783","type":"posted-content","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:40:27Z","timestamp":1756924827000},"source":"Crossref","is-referenced-by-count":0,"title":["Platelet factor 4 modulates endothelial cell antimicrobial activity to enhance bacterial clearance and improve sepsis outcomes"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-6584","authenticated-orcid":false,"given":"Anh T. P.","family":"Ngo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weronika","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nate","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-3077","authenticated-orcid":false,"given":"Lubica","family":"Rauova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Chernysh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Goulian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-4709","authenticated-orcid":false,"given":"Kandace","family":"Gollomp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025090813350990000_2025.09.02.673783v1.1","doi-asserted-by":"publisher","DOI":"10.1007\/S00134-021-06506-Y"},{"key":"2025090813350990000_2025.09.02.673783v1.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319821"},{"key":"2025090813350990000_2025.09.02.673783v1.3","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13699"},{"key":"2025090813350990000_2025.09.02.673783v1.4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301147"},{"key":"2025090813350990000_2025.09.02.673783v1.5","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314645"},{"key":"2025090813350990000_2025.09.02.673783v1.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3994"},{"key":"2025090813350990000_2025.09.02.673783v1.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-081901"},{"issue":"10","key":"2025090813350990000_2025.09.02.673783v1.8","first-page":"743","article-title":"Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis","volume":"135","year":"2020","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"2025090813350990000_2025.09.02.673783v1.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3574"},{"issue":"7","key":"2025090813350990000_2025.09.02.673783v1.10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V84.7.2329.2329","article-title":"Structural requirements of platelet chemokines for neutrophil activation","volume":"84","year":"1994","journal-title":"Blood"},{"key":"2025090813350990000_2025.09.02.673783v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20109"},{"key":"2025090813350990000_2025.09.02.673783v1.12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.760660"},{"key":"2025090813350990000_2025.09.02.673783v1.13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016000877"},{"key":"2025090813350990000_2025.09.02.673783v1.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018881607"},{"key":"2025090813350990000_2025.09.02.673783v1.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478966"},{"key":"2025090813350990000_2025.09.02.673783v1.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301424"},{"key":"2025090813350990000_2025.09.02.673783v1.17","doi-asserted-by":"crossref","first-page":"1217103","DOI":"10.3389\/fcimb.2023.1217103","article-title":"Platelet factor 4 improves survival in a murine model of antibiotic-susceptible and methicillin-resistant Staphylococcus aureus peritonitis","volume":"13","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090813350990000_2025.09.02.673783v1.18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171054"},{"key":"2025090813350990000_2025.09.02.673783v1.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-830737"},{"key":"2025090813350990000_2025.09.02.673783v1.20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021897"},{"key":"2025090813350990000_2025.09.02.673783v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646789"},{"key":"2025090813350990000_2025.09.02.673783v1.22","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-61"},{"issue":"5","key":"2025090813350990000_2025.09.02.673783v1.23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.micinf.2015.01.005","article-title":"The innate defense antimicrobial peptides hBD3 and RNase7 are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokines","volume":"17","year":"2015","journal-title":"Microbes Infect"},{"key":"2025090813350990000_2025.09.02.673783v1.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005603"},{"key":"2025090813350990000_2025.09.02.673783v1.25","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-12-0894"},{"key":"2025090813350990000_2025.09.02.673783v1.26","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.108.3.967"},{"key":"2025090813350990000_2025.09.02.673783v1.27","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00279"},{"key":"2025090813350990000_2025.09.02.673783v1.28","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13955"},{"key":"2025090813350990000_2025.09.02.673783v1.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1544"},{"key":"2025090813350990000_2025.09.02.673783v1.30","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6524-6533.2002"},{"key":"2025090813350990000_2025.09.02.673783v1.31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.27.20374"},{"key":"2025090813350990000_2025.09.02.673783v1.32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208894200"},{"key":"2025090813350990000_2025.09.02.673783v1.33","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-233"},{"key":"2025090813350990000_2025.09.02.673783v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230544"},{"key":"2025090813350990000_2025.09.02.673783v1.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-020-00691-1"},{"issue":"4","key":"2025090813350990000_2025.09.02.673783v1.36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/bjh.19663","article-title":"Anti-platelet factor 4 immunothrombotic syndromes","volume":"205","year":"2024","journal-title":"Br J Haematol"},{"issue":"13","key":"2025090813350990000_2025.09.02.673783v1.37","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.3390\/ijms26136114","article-title":"Immunothrombosis in sepsis: Cellular crosstalk, molecular triggers, and therapeutic opportunities-A review","volume":"26","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2025090813350990000_2025.09.02.673783v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06436-3"},{"issue":"1","key":"2025090813350990000_2025.09.02.673783v1.39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12871-025-03188-7","article-title":"The clinical significance of thrombocytopenia in sepsis and septic shock: a systematic review and meta-analysis","volume":"25","year":"2025","journal-title":"BMC Anesthesiol"},{"issue":"8","key":"2025090813350990000_2025.09.02.673783v1.40","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.91.8.2188","article-title":"Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans","volume":"91","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"2025090813350990000_2025.09.02.673783v1.41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0038-1645072","article-title":"Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation","volume":"63","year":"1990","journal-title":"Thromb Haemost"},{"issue":"21","key":"2025090813350990000_2025.09.02.673783v1.42","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.3390\/jcm12216921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"2025090813350990000_2025.09.02.673783v1.43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2025090813350990000_2025.09.02.673783v1.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-479576"},{"issue":"5","key":"2025090813350990000_2025.09.02.673783v1.45","first-page":"45","article-title":"Comparative echographic and computed tomographic studies of acute focal bacterial nephritis","volume":"29","year":"1990","journal-title":"Vutr Boles"},{"key":"2025090813350990000_2025.09.02.673783v1.46","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0154-9_26"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.09.02.673783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:29:25Z","timestamp":1768469365000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.09.02.673783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1101\/2025.09.02.673783","relation":{},"subject":[],"published":{"date-parts":[[2025,9,3]]},"subtype":"preprint"}}